The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

Guizhou Bailing Group Pharmaceutical

Status and phase: Completed; Phase 2

Conditions: General Disorders and Administration Site Conditions

Treatments: Drug: Tangning Tongluo Capsule

Study type: Interventional

Funder types: Industry

Identifiers

NCT02174042

TNTL-14-03

Details and patient eligibility

About

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule.

Full description

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule,a traditional Chinese Miao medicine, in Type 2 Diabetics.

Enrollment: 120 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. diagnosis of type 2 diabetes for more than one year.
2. the sustained follow-up time >3 month.
3. TNTL single or combined treatment time >3 month.
4. Chinese ethnicity.

Exclusion criteria

1. the medical record information is not original and available.
2. lactating or pregnant.
3. diagnosis of heart failure, acute myocardial infarction, stroke, or serious injuries.
4. any other conditions not suitable for trial as evaluated by the physician in charge.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

120 participants in 1 patient group

Tangning Tongluo Capsule

Experimental group

Description:

Type 2 diabetes

Treatment:

Drug: Tangning Tongluo Capsule